Plk1 Control of p31comet in Mitotic Checkpoint Disassembly
2026-09-09
The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet–TRIP13-mediated mitotic checkpoint complex disassembly. By mapping the relevant phosphorylation site to S102 and testing an S102A mutant, the work provides a mechanistic explanation for how cells may prevent premature checkpoint silencing during active mitosis.
Cabazitaxel (XRP6258): Practical Workflow Guide
2026-09-08
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble taxane derivative for controlled antiproliferative assays and studies of taxane-resistant cancer models. This guide covers solvent selection, preparation, exposure planning, and QC while defining why direct aqueous preparation and long-term solution storage should be avoided.
Melatonin Targets RIPK3 in Atrazine Kidney Injury
2026-09-08
The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway. By combining in vivo and in vitro injury models with RIPK3 knockdown and computational structural analysis, the work links melatonin treatment to reduced necroptotic signaling, mitochondrial dysfunction, and inflammation.
2-DG and the Next Frontier of Immunometabolism
2026-09-07
2-Deoxy-D-glucose is more than a glycolysis inhibitor. Used strategically, 2-DG can help translational researchers interrogate how energy stress, tumor-cell fitness, macrophage programming, and antiviral responses intersect. This article connects the metabolic mechanism of 2-DG with findings from the 2024 Immunity study on 25-hydroxycholesterol, AMPK, STAT6, and immunosuppressive tumor-associated macrophages, while providing practical guidance for experimental design and translational interpretation.
DPPH Antioxidant Screening Workflow
2026-09-05
Use DPPH for rapid, plate-based ranking of electron- and hydrogen-donating activity in purified compounds, extracts, and cultivation samples. Pair its fast colorimetric readout with orthogonal antioxidant assays and chemical profiling to distinguish a useful screening signal from a translational lead.
Fzd4 N-Glycosylation in Wnt–β-Catenin Signalling
2026-09-05
The reference study identifies Asn59 and Asn144 as conserved N-glycosylation sites on Fzd4 and shows that these modifications support receptor maturation, stability, plasma-membrane trafficking, and signalling. Mutant-rescue experiments in A549 cells and nude-mouse tumour models connect defective Fzd4 glycosylation with reduced non-small cell lung cancer growth and migration, while also highlighting important questions about glycan occupancy and mechanism.
ZK53: Human Mitochondrial ClpP Activator
2026-09-04
ZK53 is a selective human mitochondrial serine protease ClpP activator that engages mitochondrial proteostasis and electron transport pathways. Reported studies show strong HsClpP activation, antiproliferative activity in H1703 lung squamous cell carcinoma cells, and ferroptosis-sensitizing activity in colorectal cancer research models.
SB-3CT: Gelatinase Inhibitor Workflow Guide
2026-09-04
SB-3CT is a research-ready gelatinase inhibitor for dissecting MMP-2 and MMP-9 activity in extracellular-matrix remodeling, perineuronal-net biology, tumor metastasis research, and ischemic injury models. This practical guide connects biochemical target validation with cellular rescue assays, experimental controls, and troubleshooting strategies.
GSK621: A Causal Probe of AMPK–TAM Metabolism
2026-09-03
GSK621 is an AMPK agonist that can help researchers dissect how energy sensing intersects with tumor-associated macrophage function. This article translates recent 25-hydroxycholesterol findings into a practical, pathway-resolved assay strategy while distinguishing direct AMPK activation from upstream lysosomal regulation.
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-09-03
Oligo (dT) 25 Beads support selective eukaryotic mRNA isolation by capturing polyadenylated transcripts from total RNA or animal and plant samples. They are appropriate for polyA-enriched mRNA workflows, but not for comprehensive recovery of non-polyadenylated RNA or as a substitute for a validated total-RNA purification method.
Melatonin, RIPK3, and Atrazine Kidney Injury
2026-09-02
The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway. By combining animal and cell models, RIPK3 knockdown, pathway analysis, and computational modeling, the work moves beyond descriptive oxidative-stress findings toward a testable mechanism for chemical nephrotoxicity.
DOT1L Inhibition Enhances Lenalidomide in Myeloma
2026-09-02
This 2025 Cancer Letters study identifies DOT1L as a preferential epigenetic dependency in multiple myeloma and connects its inhibition to DNA damage-associated STING signaling, type I interferon responses, and increased HLA class II expression. The work further shows that DOT1L inhibition can potentiate lenalidomide by strengthening innate immune gene activation and suppressing IRF4–MYC signaling.
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-01
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cells and tissues. It is appropriate for carbohydrate-focused immunofluorescence and flow cytometry workflows, but not for non-carbohydrate targets or assays that compromise the required divalent-ion environment.
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-08-31
This 2024 zebrafish study identifies Stat3 as a previously underappreciated downstream effector of hyperactive Fyn signaling in dopaminergic neuron loss and microglial inflammation. Its combination of cell-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a practical framework for separating neuronal and inflammatory mechanisms in neurodegeneration research.
Ibuprofen Toxicology and Biodegradation: Review Insights
2026-08-31
This review frames ibuprofen as an emerging contaminant by connecting widespread use, environmental persistence, organism-level toxicity, and incomplete removal in wastewater systems. Its central contribution is the evaluation of bacterial biodegradation as a promising but still insufficiently developed complement to conventional pharmaceutical-contaminant management.
463 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page